Our research reveals the prognostic and pro-metastatic roles for CASC9 in ESCC, suggesting that CASC9 could serve as a biomarker for prognosis and a target for metastasis treatment. The gene discussed is CASC9; the disease is esophageal squamous cell carcinoma.